Home LiteratureArticle Details
PMID: 3514676 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.

The Journal of clinical investigation ·Vol. 77 ·No. 4 ·1986-04-00 ·Pages 1194-200

Bray GL, Thompson AR

Abstract

A partial gene product was identified in a pedigree with hemophilia B due to a partial deletion of the Factor IX gene (Chen, S.-H.,S. Yoshitake, P.F. Chance, G.L. Bray, A.R. Thompson, C.R. Scott, and K. Kurachi, 1985, J. Clin. Invest., 76:2161-2164). Levels of this mutant protein in plasma of affected family members studied ranged from 24 to 36 ng/ml (0.6-0.9 U/dl or percent of normal) by a solid-phase immunoassay which is sensitive and specific for the calcium-dependent conformation of human Factor IX. No Factor IX antigen could be detected in patients' plasmas by a non-calcium-requiring monoclonal anti-Factor IX antibody (less than 2 ng/ml). The unconcentrated urine from the five affected family members and four obligate heterozygotes the five affected family members and four obligate heterozygotes tested contained calcium-dependent Factor IX antigen levels ranging from 64 to 160 ng/ml (1.6-4.0 U/dl) and from 10 to 68 ng/ml (0.25-1.7 U/dl), respectively. Of nine normal volunteers screened, three had detectable calcium-dependent antigen in unconcentrated first morning-voided urines with 9.6-16.8 ng/ml (0.24-0.42 U/dl), while the remaining six had detectable urinary antigen only after a 10-fold concentration. Abnormal and normal urinary Factor IX antigen species were concentrated, immunoaffinity purified, electrophoresed, immunoblotted, and distinguished by autoradiography after incubation with 125I-polyclonal calcium-requiring anti-Factor IX. After reducing purified or concentrated samples, a single abnormal 36,000-mol-wt band was identified in the urines from the four affected family members and four obligate heterozygotes tested. Electrophoresis of the reduced urinary Factor IX antigen from the one normal subject tested showed a broad 15,000-20,000-mol-wt band. This normal band was smaller than the species in patients' urines, and was seen as a minor component in the samples from the heterozygotes. No abnormal antigen could be detected in urine from the two other female family members tested. Thus, abnormal urinary Factor IX antigen represents a marker for the presence of the hemophilic Factor IX gene in this family.

MeSH Terms
Antibodies Calcium/metabolism Chromosome Deletion Electrophoresis, Polyacrylamide Gel Factor IX/genetics,urine Female Hemophilia B/genetics Humans Immunologic Techniques Male Molecular Weight Pedigree
Chemicals
Antibodies Factor IX Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bray G L
Thompson A R
References (22)
22 references, click to expand
  1. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.
    J Immunol. 1975 Dec;115(6):1617-24 PMID: 1102604
  2. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.
    J Biol Chem. 1969 Aug 25;244(16):4406-12 PMID: 5806584
  3. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  4. Labeled factor IX kinetics in patients with hemophilia-B.
    Blood. 1981 Sep;58(3):625-9 PMID: 7259841
  5. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thromb Haemost. 1982 Aug 24;48(1):27-32 PMID: 6813992
  6. Gene deletions in patients with haemophilia B and anti-factor IX antibodies.
    Nature. 1983 May 12-18;303(5913):181-2 PMID: 6843667
  7. Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients.
    Blood. 1983 Nov;62(5):1027-34 PMID: 6194835
  8. Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).
    Lancet. 1984 Feb 4;1(8371):242-3 PMID: 6142993
  9. The gene structure of human anti-haemophilic factor IX.
    EMBO J. 1984 May;3(5):1053-60 PMID: 6329734
  10. Overview of inhibitors to factor VIII and IX.
    Prog Clin Biol Res. 1984;150:1-18 PMID: 6431420
  11. Inhibitors in Christmas disease.
    Prog Clin Biol Res. 1984;150:123-39 PMID: 6463063
  12. Measurement of factor VIII inhibitors.
    Prog Clin Biol Res. 1984;150:87-98 PMID: 6431444
  13. Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis.
    Blood. 1984 Oct;64(4):867-74 PMID: 6478059
  14. Quantitation of prothrombin activation products in human urine.
    Br J Haematol. 1984 Dec;58(4):597-606 PMID: 6549141
  15. Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.
    Proc Natl Acad Sci U S A. 1985 Jun;82(11):3879-83 PMID: 2408269
  16. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).
    Biochemistry. 1985 Jul 2;24(14):3736-50 PMID: 2994716
  17. An intragenic deletion of the factor IX gene in a family with hemophilia B.
    J Clin Invest. 1985 Dec;76(6):2161-4 PMID: 3001143
  18. Structure, function, and molecular defects of factor IX.
    Blood. 1986 Mar;67(3):565-72 PMID: 3511981
  19. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
    J Lab Clin Med. 1986 Mar;107(3):269-78 PMID: 3485164
  20. Monoclonal antibodies to coagulation factor IX define a high-frequency polymorphism by immunoassays.
    Am J Hum Genet. 1985 Jul;37(4):668-79 PMID: 9556657
  21. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.
    Am J Clin Pathol. 1961 Sep;36:212-9 PMID: 13738153
  22. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    J Clin Invest. 1977 May;59(5):900-10 PMID: 856873
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1986-04-00
Pages
1194-200
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC424456
Subset
IM
Grants
NHLBI NIH HHS · HL-31193 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]